Belinsky SA - Search Results

1

Gene-promoter hypermethylation as a biomarker in lung cancer.

Belinsky SA. Belinsky SA. Nat Rev Cancer. 2004 Sep;4(9):707-17. doi: 10.1038/nrc1432. Nat Rev Cancer. 2004. PMID: 15343277 Review.

2

Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure.

Issa JP, Baylin SB, Belinsky SA. Issa JP, et al. Among authors: belinsky sa. Cancer Res. 1996 Aug 15;56(16):3655-8. Cancer Res. 1996. PMID: 8706002

3

p16INK4a and beta-catenin alterations in rat liver tumors induced by NNK.

Pulling LC, Klinge DM, Belinsky SA. Pulling LC, et al. Among authors: belinsky sa. Carcinogenesis. 2001 Mar;22(3):461-6. doi: 10.1093/carcin/22.3.461. Carcinogenesis. 2001. PMID: 11238187

4

SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.

Tessema M, Yingling CM, Thomas CL, Klinge DM, Bernauer AM, Liu Y, Dacic S, Siegfried JM, Dahlberg SE, Schiller JH, Belinsky SA. Tessema M, et al. Among authors: belinsky sa. Oncogene. 2012 Sep 13;31(37):4107-16. doi: 10.1038/onc.2011.577. Epub 2011 Dec 12. Oncogene. 2012. PMID: 22158045 Free PMC article.

5

Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum.

Belinsky SA, Grimes MJ, Casas E, Stidley CA, Franklin WA, Bocklage TJ, Johnson DH, Schiller JH. Belinsky SA, et al. Br J Cancer. 2007 Apr 23;96(8):1278-83. doi: 10.1038/sj.bjc.6603721. Epub 2007 Apr 3. Br J Cancer. 2007. PMID: 17406356 Free PMC article.

6

Predicting lung cancer by detecting aberrant promoter methylation in sputum.

Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. Palmisano WA, et al. Among authors: belinsky sa. Cancer Res. 2000 Nov 1;60(21):5954-8. Cancer Res. 2000. PMID: 11085511

7

Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.

Teneng I, Tellez CS, Picchi MA, Klinge DM, Yingling CM, Snider AM, Liu Y, Belinsky SA. Teneng I, et al. Among authors: belinsky sa. Oncogene. 2015 Jan 29;34(5):621-30. doi: 10.1038/onc.2013.580. Epub 2014 Jan 27. Oncogene. 2015. PMID: 24469050

8

Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model.

Reed MD, Tellez CS, Grimes MJ, Picchi MA, Tessema M, Cheng YS, March TH, Kuehl PJ, Belinsky SA. Reed MD, et al. Among authors: belinsky sa. Br J Cancer. 2013 Oct 1;109(7):1775-81. doi: 10.1038/bjc.2013.575. Epub 2013 Sep 17. Br J Cancer. 2013. PMID: 24045660 Free PMC article.

9

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis.

Tessema M, Klinge DM, Yingling CM, Do K, Van Neste L, Belinsky SA. Tessema M, et al. Among authors: belinsky sa. Oncogene. 2010 Sep 16;29(37):5159-70. doi: 10.1038/onc.2010.255. Epub 2010 Jun 21. Oncogene. 2010. PMID: 20562917 Free PMC article.

10

Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions.

Wardlaw SA, March TH, Belinsky SA. Wardlaw SA, et al. Among authors: belinsky sa. Carcinogenesis. 2000 Jul;21(7):1371-7. Carcinogenesis. 2000. PMID: 10874016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results